Year
Edition number
№1 / 2024
PROFILE COMMISSION
Shilov E.M., Shilova M.M., Rumyantseva E.I., Batyushin M.M., Bevzenko A.Yu., Belskikh A.N., Veselkova N.V., Yesayan A.M., Ivliev S.V., Kotenko O.N., Petrova N.Yu., Statsenko M.E., Stolyar A.G.
Nephrological service of the Russian Federation 2023: Part I. Renal Replacement Therapy5-14
ORIGINAL PAPERS
Krysanov I.S., Makarova E.V., Ermakova V.Yu., Kurkin D.V.
Comparative pharmacoeconomic analysis of the use of epoetin alfa and roxadustat in combination with iron supplements in adult patients with anemia against the background of chronic kidney disease in the healthcare system of the Russian Federation15-24
Sokolova A.V., Dragunov D.O., Arutyunov G.P.
Screening for sarcopenia in patients with chronic heart failure and chronic kidney disease25-29
Kurylovich K.A., Komissarov K.S., Krasko O.V.
Prognostic value of the Charlson comorbidity index i n patients aged 60 years and older starting chronic dialysis treatment30-36
Pivovarov D.V., Mikhailova Z.D.
Application of kidney injury molecule-1 (KIM-1) for predicting urgent cardiovascular complications in acute cardiorenal syndrome37-42
Grigoryan Z.E., Marchenko Ya.M., Khachatryan M.V.
Features of the course and the prognosis in patients with multiple myeloma depending on the renal involvement43-48
Avdeeva V.A., Syachina S.N., Ejrih V.V., Zhmurov D.V., Zhmurov V.A.
Secondary hyperparathyroidism in patients with chronic kidney disease in Tyumen region: five-year follow-up data49-53
KIDNEY DISEASES
Daminov B.T., Azizov S.K., Sharapov O.N., Safoeva Sh.F.
The first case of successful pregnancy and natural childbirth in a patient on program hemodialysis in Uzbekistan54-57
LITERATURE REVIEWS
Ryasnyansky V.Yu., Shostka G.D., Anikonova L.I.
Nephrogenic anemia in patients receiving renal replacement therapy, pathogenesis and resistance58-66
Butranova O.I., Zyryanov S.K.
Quality of life in diabetic patients with chronic kidney disease67-74
Dudnikova A.V., Mekhrabov R.A., Alieva A.R., Gish Z.A., Leontyev A.A., Rasskazova D.A.
Modern concepts of the role of asymptomatic hyperuricemia in the formation of chronic kidney disease and cardiovascular risk75-80
